Pediatric behavioral and affective disorders often require antipsychotic therapy, in
combination with psychotherapeutic interventions, for their treatment and stabilization …

Context Although antipsychotic treatment has recently increased, little is known about how
this development has differentially affected the office-based care of adults and young people …

Recent reports of antipsychotic medication use in pediatric populations describe large
increases in rates of use. Much interest in the increasing use has focused on potentially …

Abnormal Child and Adolescent Psychology is a comprehensive introduction to the field. It
covers theoretical and methodological foundations and examines the characteristics …

Aripiprazole and risperidone are the only FDA approved medications for treating irritability in
autistic disorder, however there are no head-to-head data comparing these agents. This is …

Objective To estimate trends of annual antipsychotic medication use by privately insured
young children (aged 2–7 years) in the United States, and to describe the clinical and …

The treatment of pediatric depression is controversial because it includes substantial
prescribing of drugs for uses that have not been approved by the Food and Drug …

Autism spectrum disorder is often comorbid with behavioral disturbances such as irritability,
aggression and hyperactivity. Throughout the mid 2000s, several large-scale controlled …

Abstract Background Both the US FDA and the European Medicines Agency (EMA) have
approved aripiprazole for use in adolescents for specific indications. Given the assumed …

Autism spectrum disorder (ASD) continues to grow in prevalence each passing year. As
more children are diagnosed, it makes sense that the emerging adult and adult population …